These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 22755428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term post transplant alloantibody monitoring: a single center experience.
    Ntokou IS, Boletis JN, Apostolaki M, Vrani V, Zavos G, Kostakis A, Iniotaki A.
    Clin Transpl; 2011; ():341-50. PubMed ID: 22755429
    [Abstract] [Full Text] [Related]

  • 6. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP, Bowers V, Baliga R, Sanders C, LeFor W, Becker D, Thompson D, Resto-Ruiz S, Lopez-Cepero M.
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [Abstract] [Full Text] [Related]

  • 7. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Understanding the significance of low-level preformed donor-specific anti-HLA antibodies in renal transplant patients.
    Wu P, Everly MJ, Jin J, Mao Y, Chen J.
    Clin Transpl; 2011; ():365-8. PubMed ID: 22755432
    [Abstract] [Full Text] [Related]

  • 10. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
    Kimball PM, King A.
    Clin Transpl; 2011; ():369-72. PubMed ID: 22755433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.
    Transplant Proc; 2011; 43(6):2154-6. PubMed ID: 21839219
    [Abstract] [Full Text] [Related]

  • 13. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 14. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
    Everly MJ.
    Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
    [Abstract] [Full Text] [Related]

  • 15. Annual literature review of donor-specific HLA antibodies after organ transplantation.
    Kaneku H.
    Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A, Oei E, Vathsala A.
    Transplant Proc; 2012 Jan 20; 44(1):193-9. PubMed ID: 22310613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.